3-hydroxy-1-benzopyran-2-one has been researched along with warfarin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbosa-Filho, JM; de Araujo Leite, JC; de Castro, TM; de Siqueira-Junior, JP; Marques-Santos, LF | 1 |
| Alavi, SJ; Eshghi, H; Sadeghian, H; Salimi, A; Seyedi, SM | 1 |
| Fornasier, M; Murgia, S; Nieddu, M; Rescigno, A; Schlich, M; Sinico, C | 1 |
3 other study(ies) available for 3-hydroxy-1-benzopyran-2-one and warfarin
| Article | Year |
|---|---|
Photoprotective effect of coumarin and 3-hydroxycoumarin in sea urchin gametes and embryonic cells.
Topics: Animals; Coumarins; Dose-Response Relationship, Drug; Embryo, Nonmammalian; Female; Male; Ovum; Protective Agents; Radiation-Protective Agents; Sea Urchins; Spermatozoa; Ultraviolet Rays; Umbelliferones; Zygote | 2015 |
A novel class of human 15-LOX-1 inhibitors based on 3-hydroxycoumarin.
Topics: Arachidonate 15-Lipoxygenase; Coumarins; Humans; Inhibitory Concentration 50; Kinetics; Lipoxygenase Inhibitors; Structure-Activity Relationship; Thermodynamics | 2018 |
3-hydroxycoumarin loaded vesicles for recombinant human tyrosinase inhibition in topical applications.
Topics: Administration, Cutaneous; Animals; Cell Proliferation; Cell Survival; Coumarins; Drug Carriers; Drug Delivery Systems; Enzyme Inhibitors; Humans; Mice; Monophenol Monooxygenase; Particle Size; Recombinant Proteins; Skin; Skin Absorption; Surface Properties; Swine; Tumor Cells, Cultured | 2018 |